RESEARCH TRIANGLE PARK, N.C., September 12, 2019 — AgBiome, Inc., a leader in harnessing the plant microbiome, has received Phase II grant funding from the Bill & Melinda Gates Foundation to continue the discovery of microbes that target sweetpotato weevils Read More
Types: Link
Press Release: Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis
University of California, Davis Study Shows up to 98% Reduction of Intestinal Inflammation Markers Linked to Colic, Eczema, Asthma and Diabetes DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ — Findings from a new study published today in Pediatric Research show that feeding activated Read More
Press Release: Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants
Breakthrough Study Reveals Activated B. infantis EVC001 as the First Infant Probiotic to Be Effective in the Fight Against Global Health Epidemic DAVIS, Calif., Aug. 14, 2019 /PRNewswire/ — Evolve BioSystems, Inc. today announced findings from a new study that identified Read More
Bloomberg: Bill Gates and Former Bass Guitarist Aim to Change Health Care
By Yoolim Lee and David Ramli July 24, 2019 Jonathan Sudharta was a brawl-prone, unremarkable student who played in a rock band. Friends of his father, a self-made tycoon, feared he’d one day take over the family medical business and ruin Read More
Nasdaq: Solid tumor biotech Atreca files for a $100 million IPO
May 24, 2019 Atreca, a preclinical biotech developing immunotherapies for solid tumors, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Redwood City, CA-based company was founded in 2010 and plans Read More
New York Times: In African Villages, These Phones Become Ultrasound Scanners
By Donald G. McNeil Jr. April 15, 2019 BUSHORO, Uganda — Lying on a church pew with his arm over his head, 6-year-old Gordon Andindagaye whimpered a bit — in fear, not pain — as Dr. William A. Cherniak slowly swept Read More
FierceBiotech: Evotec to acquire Gates Foundation-backed Just Biotherapeutics
By Ben Adams May 21, 2019 Biotech-CRO hybrid Evotec is continuing its deals, buys and collaborations strategy with its acquisition of U.S. biologics company Just Biotherapeutics. The German company is spending a small sum, just $90 million, on its latest purchase, Read More
Press Release: Evotec jump-starts biologics with acquisition of Just Biotherapeutics
May 20, 2019 Hamburg, Germany: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based Read More
PR Newswire: The Global Health Investment Fund and Medicines Development for Global Health Announce the Sale of Priority Review Voucher
May 07, 2019 NEW YORK and MELBOURNE, Australia, May 7, 2019 /PRNewswire/ — The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (MDGH) today announced the sale of MDGH’s Priority Review Voucher (PRV). The PRV was awarded to MDGH in June 2018 by the U.S. Food & Drug Read More
Business Wire: Lyndra Therapeutics Raises $55 Million in Series B Financing
January 29, 2019 WATERTOWN, Mass.–(BUSINESS WIRE)– Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, Read More